Promote Scientific Collaboration
Access to Unique Applications and Tools
HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
|Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool.
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
- CRISPR-based drugs: one giant leap for mankind
- Making babies: having a family, the HD way
- Steady progress from uniQure - promising data to end the year
- Putting it in print: GENERATION HD1 study results published
- Regulating repetition: Gaining control of CAG repeats could slow progression of Huntington’s disease
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Huntington disease - Update on ongoing therapeutic developments and a look toward the future
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Large-scale screening of clinical assessments to distinguish between states in the Integrated HD Progression Model (IHDPM)
- The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease
- Scott Porter Brings Son McCoy and Daughter Clover to 'Epic' Pokémon Event
- Introducing Unlearn's TrialPioneer: A Free Tool for Exploring Innovative Clinical Trial ...
- Rare Disease Day 2024: The importance of amplifying voices and bridging health-care gaps in SA
- Goldman Sachs slashes uniQure stock PT to $8 from $63.00 amid AMT-130 concerns
- Newcastle United co-owner Amanda Staveley faces bankruptcy in £36m row with ex ...